• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs could affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to best adhd medication uk medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must consider the benefits of taking it against the potential risks for the foetus. Doctors don't have the information needed to make unequivocal recommendations but they can provide information about benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a greater risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who used stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to ensure that the classification was accurate and to minimize any bias.

The study of the researchers was not without its limitations. The most important issue was that they were unable to separate the effects of the medication from the effects of the disorder at hand. This limitation makes it difficult for researchers to establish whether the few associations observed between the groups that were exposed to the use of medication or if they were confounded by comorbidities. In addition, the researchers did not examine the long-term effects of offspring on their parents.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had taken off their medication prior to or during pregnancy. This was due to central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medication during pregnancies in the early stages may be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, if they are able, assist them in developing strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether to continue or stop treatment during pregnancy is one that doctors are having to have to face. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge and experience, as well as the experiences of other doctors, and the research that has been conducted on the subject.

The issue of risk to the infant can be particularly tricky. The research that has been conducted on this topic is based on observation instead of controlled studies and the results are conflicting. Furthermore, most studies restrict their analysis to live births, which can undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

Conclusion: While some studies have shown a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. most common adhd Medications studies have shown that there is a neutral, or slight negative effect. In every case it is imperative to conduct a thorough evaluation of the benefits and risks must be performed.

For many women with ADHD who suffer from ADHD, the decision to stop medication is difficult if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. Furthermore, a loss of medication can interfere with the ability to perform jobs and drive safely that are crucial aspects of daily life for a lot of people with adhd medication not working.

She recommends women who are unsure about whether to keep or stop medication in light of their pregnancy should consider educating family members, friends and colleagues on the condition, its impact on daily life, and the benefits of keeping the current treatment plan. It will also help a woman feel more confident in her decision. It is also worth noting that some medications can pass through the placenta, so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns over the impact that these drugs could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Researchers used two huge data sets to study over 4.3 million pregnancies and determine if stimulant medication use increased birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medications was associated with a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers types of adhd medication the study did not discover any connection between early use of medication and other congenital anomalies like facial deformities, or club feet. The results are in line with previous studies that have shown a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication before the time of pregnancy. The risk grew in the latter half of pregnancy, as many women begin to discontinue their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery or have a low Apgar after delivery, and had a baby that required help breathing after birth. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who did not have any other medical issues that could have contributed to these findings.

The researchers hope their research will aid in the clinical decisions of doctors who treat pregnant women. The researchers suggest that while discussing benefits and risks are crucial, the decision about whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, even though stopping the medication is a possibility to think about, it isn't recommended because of the high incidence of depression and other mental disorders in women who are expecting or recently gave birth. Research has also shown that women who stop taking their medications will have a difficult time adjusting to a life without them after the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments, making preparations for the arrival of their child and adapting to new routines in the home can experience severe challenges. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant drugs are absorbed by breast milk in small amounts, therefore the risk for infant who is breastfeeding is low. However, the rate of exposure to medication by the infant can differ based on dosage, frequency it is taken and the time of the day it is administered. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn is not fully understood.

Because of the lack of research, some physicians might be tempted to stop taking stimulant medication during a woman's pregnancy. It's a difficult choice for the woman who must weigh the benefits of her medication against the risk to the fetus. As long as there is no more information, GPs should ask all pregnant patients about their history of ADHD and if they are taking or planning to take medication during the perinatal period.

A growing number of studies have proven that women can continue to take their ADHD medication while they are pregnant and nursing. In response, an increasing number of patients are choosing to do this. They have discovered through consultation with their doctors, that the benefits of continuing their current medication outweigh any possible risks.

Women with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non stimulant adhd medication list-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD understand their symptoms and the root cause and learn about treatment options and reinforce existing strategies for managing. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a treatment plan for both mother and child, monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.